Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome
Trial details
- Registry ID
- NCT06527937
- Drugs studied
- DESF, Epinephrine Injection
TrialRedline tracks 1 clinical trial sponsored by Aquestive Therapeutics: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Pharmacokinetics Study of DESF in Adults With Oral Allergy SyndromeNCT06527937 | DESF, Epinephrine Injection | Completed | 2024-10-10Actual |
Names as written in the registry records.